Seed Incubator,
LinDo K.K.

Creating an environment
that enables the global level of choice
of new drugs

LinDo’s Goal

Addressing the Issue of “Drug Loss”
And Offering the Option of Hope

LinDo K.K. is a pharmaceuticals seed incubator that specializes in licensing new therapeutic drugs, including those for rare disorders and intractable diseases, being developed by emerging biopharma (EBP) companies in Europe and the US, and developing those drugs, obtaining approval for them, and marketing them in Japan. LinDo engages in the development of new drugs that, despite being innovative, have little chance of being developed in Japan, to offer the option of hope to patients who are waiting eagerly for the emergence of new drugs that will cure their conditions and to the physicians and healthcare professionals who treat those patients.

To page top